VitruvianMD, a pioneering medtech startup, has raised an impressive $1.25 million (equivalent to over R23 million) in their recent Seed Extension II funding round. The funding, led by 27four‘s social impact venture capital fund, The Nebula Fund, marks a significant milestone for the company as it propels its innovative technology forward. VitruvianMD’s cutting-edge solutions combine biomedical engineering and advanced artificial intelligence (AI) to redefine accessibility in the medical laboratory sphere.
RELATED: Xeltis concludes D2 financing with additional €12.5m from EIC Fund
